Catalent has a total of 2186 patents globally, out of which 1124 have been granted. Of these 2186 patents, more than 48% patents are active. United States of America is where Catalent has filed the maximum number of patents, followed by Europe and Japan. Parallelly, USA seems to be the main focused R&D center and also is the origin country of Catalent.
Catalent was founded in 2007. Catalent provides delivery technologies and development solutions for drugs, biologics, and consumer health products. The Company’s oral, injectable, and respiratory delivery technologies address the diversity of the pharmaceutical industry including small molecules, large molecule biologics, and consumer health products. As of May 2022, Catalent has a market cap of $17.90 Billion.
Do read about some of the most popular patents of Catalent which have been covered by us in this article and also you can find Catalent patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Catalent patent portfolio.
How many patents does the CEO of Catalent have?
The CEO John Chiminski has 0 patents.
How many patents does Catalent have?
Catalent has a total of 2186 patents globally. These patents belong to 417 unique patent families. Out of 2186 patents, 1068 patents are active.
How Many Patents did Catalent File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Catalent Applications Filed | Catalent Patents Granted |
| 2011 | 106 | 36 |
| 2012 | 54 | 40 |
| 2013 | 61 | 34 |
| 2014 | 93 | 26 |
| 2015 | 93 | 35 |
| 2016 | 59 | 44 |
| 2017 | 88 | 50 |
| 2018 | 32 | 44 |
| 2019 | 135 | 70 |
| 2020 | 166 | 64 |
| 2021 | 70 | 96 |
| 2022 | 2 | 14 |
Explore the top-performing drugs that dominate the Pharmaceutical Industry
| Patent Number | Company | Product | Brand | Revenue | Patent Expiry Date |
| US9174975 | Sumitomo Pharma | Lurasidone Hydrochloride | Latuda | $1.75B | Jun-26 |
| US7612199 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7902206 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US8158644 | Alfasigma | Rifaximin | Xifaxan | $1.64B | Nov-24 |
| US7371727 | Ironwood Pharma | Linaclotide | Linzess | $1.00B | Mar-25 |
Want to know which drugs are making over $1 Billion annually?
How many Catalent patents are Alive/Dead?
Worldwide Patents
How Many Patents did Catalent File in Different Countries?
Countries in which Catalent Filed Patents
| Country | Patents |
| United States Of America | 218 |
| Europe | 161 |
| Japan | 160 |
| Australia | 124 |
| Germany | 94 |
| Canada | 87 |
| Spain | 87 |
| Brazil | 86 |
| Mexico | 75 |
| India | 71 |
| Hong Kong (S.A.R.) | 63 |
| China | 63 |
| Korea (South) | 63 |
| Argentina | 62 |
| Denmark | 58 |
| Israel | 48 |
| Portugal | 43 |
| Austria | 40 |
| Taiwan | 29 |
| Poland | 28 |
| New Zealand | 28 |
| Malaysia | 25 |
| Hungary | 23 |
| Singapore | 22 |
| Philippines | 21 |
| South Africa | 19 |
| Indonesia | 19 |
| United Kingdom | 18 |
| Slovenia | 18 |
| Russia | 16 |
| Chile | 15 |
| Norway | 15 |
| Colombia | 14 |
| Italy | 11 |
| Ukraine | 10 |
| Viet Nam | 10 |
| Czech Republic | 8 |
| Peru | 8 |
| Turkey | 8 |
| Romania | 8 |
| Cyprus | 7 |
| Georgia | 7 |
| Croatia | 6 |
| Morocco | 6 |
| Slovakia | 5 |
| Serbia | 5 |
| Kazakhstan | 4 |
| Uruguay | 4 |
| Iceland | 4 |
| Montenegro | 4 |
| Yugoslavia/Serbia and Montenegro | 3 |
| Lithuania | 2 |
| Saudi Arabia | 2 |
| Estonia | 2 |
| Finland | 2 |
| Albania | 2 |
| Bulgaria | 2 |
| France | 2 |
| Former Yugoslav Republic of Macedonia | 1 |
| Bolivia | 1 |
| Costa Rica | 1 |
Where are Research Centers of Catalent Patents Located?
10 Best Catalent Patents
US6680071B1 is the most popular patent in the Catalent portfolio. It has received 178 citations so far from companies like Boehringer Ingelheim, Cima Labs Inc and Purdue Pharma.
Below is the list of 10 most cited patents of Catalent:
| Publication Number | Citation Count |
| US6680071B1 | 178 |
| US6509040B1 | 168 |
| US6340473B1 | 162 |
| US6709669B1 | 117 |
| US6852510B2 | 98 |
| US20030232076A1 | 81 |
| US6652880B1 | 80 |
| US6624200B2 | 76 |
| US6582727B2 | 76 |
| US6413549B2 | 71 |
What Percentage of Catalent US Patent Applications were Granted?
Catalent (Excluding its subsidiaries) has filed 166 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 130 have been granted leading to a grant rate of 82.2%.
Below are the key stats of Catalent patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Catalent?
| Law Firm | Total Application | Success Rate |
| Cardinal Health | 28 | 92.86% |
| Venable Llp | 24 | 50.00% |
| Casimir Jones Sc | 17 | 53.33% |
| Catalent Pharma Solutions Inc | 17 | 91.67% |
| Bozicevic Field & Francis Llp | 10 | 100.00% |
| Mendelsohn Dunleavy Pc | 10 | 90.00% |
| Goodwin Procter Llp | 8 | 100.00% |
| Donald O Nickey | 7 | 100.00% |
| Bernhard Kreten | 3 | 100.00% |
| Cooley Llp | 3 | 66.67% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Catalent key innovation segments?